BIOMAT Database Logo BIOMAT Database Logo

The stereospecific suicide inhibition of human melanoma thioredoxin reductase by 13-cis-retinoic acid. 1989

K U Schallreuter, and J M Wood
Department of Dermatology, University of Hamburg, FRG.

13-cis retinoic acid has been shown to be a stereospecific suicide inhibitor of thioredoxin reductase purified from human melanoma tissue. All trans retinoic acid does not inhibit this enzyme. The covalent addition of 13-cis retinoic acid to the thiolate active site of thioredoxin reductase produces a thioether enzyme-inhibitor complex. This has been established by a kinetic analysis and by active site labeling with 3H-13 cis retinoic acid. A mechanism involving Michael addition of the thiolate group in the active site of thioredoxin reductase to the 13-cis double bond of enzyme-bound inhibitor has been proposed. This reaction may be important in the human epidermis because thioredoxin reductase has been shown to be a major antioxidant catalyst in human keratinocytes, melanocytes, melanoma cells, and in human skin as well as in melanoma tissues.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D009247 NADH, NADPH Oxidoreductases A group of oxidoreductases that act on NADH or NADPH. In general, enzymes using NADH or NADPH to reduce a substrate are classified according to the reverse reaction, in which NAD+ or NADP+ is formally regarded as an acceptor. This subclass includes only those enzymes in which some other redox carrier is the acceptor. (Enzyme Nomenclature, 1992, p100) EC 1.6. Oxidoreductases, NADH, NADPH,NADPH Oxidoreductases NADH,Oxidoreductases NADH, NADPH
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D004817 Epidermis The external, nonvascular layer of the skin. It is made up, from within outward, of five layers of EPITHELIUM: (1) basal layer (stratum basale epidermidis); (2) spinous layer (stratum spinosum epidermidis); (3) granular layer (stratum granulosum epidermidis); (4) clear layer (stratum lucidum epidermidis); and (5) horny layer (stratum corneum epidermidis).
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013880 Thioredoxin-Disulfide Reductase A FLAVOPROTEIN enzyme that catalyzes the oxidation of THIOREDOXINS to thioredoxin disulfide in the presence of NADP+. It was formerly listed as EC 1.6.4.5 Thioredoxin Reductase (NADPH),NADP-Thioredoxin Reductase,NADPH-Thioredoxin Reductase,Thioredoxin Reductase,NADP Thioredoxin Reductase,NADPH Thioredoxin Reductase,Reductase, NADP-Thioredoxin,Reductase, NADPH-Thioredoxin,Reductase, Thioredoxin,Reductase, Thioredoxin-Disulfide,Thioredoxin Disulfide Reductase

Related Publications

K U Schallreuter, and J M Wood
Inhibition of microsomal lipid peroxidation by 13-cis-retinoic acid.
January 1990, Methods in enzymology,
K U Schallreuter, and J M Wood
Inhibition of hamster buccal pouch carcinogenesis by 13-cis-retinoic acid.
July 1980, Oral surgery, oral medicine, and oral pathology,
K U Schallreuter, and J M Wood
Inhibition of liver microsomal lipid peroxidation by 13-cis-retinoic acid.
January 1990, Free radical biology & medicine,
K U Schallreuter, and J M Wood
Identification of 4-oxo-13-cis-retinoic acid as the major metabolite of 13-cis-retinoic acid in human blood.
January 1981, Drug metabolism and disposition: the biological fate of chemicals,
K U Schallreuter, and J M Wood
Human neuroblastoma cells and 13-cis-retinoic acid.
January 1985, Journal of neuro-oncology,
K U Schallreuter, and J M Wood
13-cis-retinoic acid: inhibition of bladder carcinogenesis in the rat.
February 1977, Science (New York, N.Y.),
K U Schallreuter, and J M Wood
Substrate specificities and 13-cis-retinoic acid inhibition of human, mouse and bovine cis-retinol dehydrogenases.
January 2000, Biochimica et biophysica acta,
K U Schallreuter, and J M Wood
Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma.
December 2014, British journal of pharmacology,
K U Schallreuter, and J M Wood
Ectopic suicide inhibition of thioredoxin glutathione reductase.
February 2020, Free radical biology & medicine,
K U Schallreuter, and J M Wood
Histopathological evaluation of the inhibition of rat bladder carcinogenesis by 13-cis-retinoic acid.
August 1977, Cancer research,
Copied contents to your clipboard!